Duration of pain relief between two drugs in upper limb surgeries

To compare effect of dexmedetomidine versus magnesium sulphate as adjuvants to 0.5% levobupivacaine in ultrasound guided supraclavicular brachial plexus block for upper limb surgeries - Nill

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058306

Enrollment

Registered

2023-10-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Duration of analgesia between dexmeditomidine versus magnesium sulphate in upper limbs surgeries: 41 patients undergoing upper limbs surgeries who will receive ultrasound guided supracl

Eligibility

Inclusion criteria

Inclusion criteria: The study will be carried out in 82 patients in age group of 18-65 years. ASA I and ASA II after approval by institutional protocol review committee.

Exclusion criteria

Exclusion criteria: 1. Patient refuses to give consent. 2. Patients who are allergic to the drugs used in this study. 3. Any history of bleeding disorder. 4. Patients on anticoagulants medications. 5. Preexisting neurological deficit or neuropathy in the upper extremities. 6. Local infection at site where block was to be given.

Design outcomes

Primary

Measure	Time frame
To compare duration of analgesia in dexmedetomidine vs magnesium sulphate as adjuvant to levobupivacaine 0.5% in ultrasound guided supraclavicular block in upper limb surgeriesTimepoint: 24hrs	—

Secondary

Measure	Time frame
Assessment for sedation levelTimepoint: 24hrs;Side effects if anyTimepoint: 24hrs	—

Countries

India

Contacts

Public ContactDr Aparna Sharma

Indira Gandhi Medical college and hospital

aparnasharmaraina@gmail.com8219712580

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026